Didanosine (ddl) and stavudine (d4T): Absence of peripheral neurotoxicity in rabbits
- 31 December 1995
- journal article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 33 (12), 1047-1050
- https://doi.org/10.1016/0278-6915(95)00078-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Zidovudine ToxicityDrug Safety, 1993
- 2',3'‐Dideoxycytidine (ddC) toxic neuropathyNeurology, 1993
- DidanosineAnnals of Pharmacotherapy, 1992
- Peripheral Nerve Function in Persons with Asymptomatic or Minimally Symptomatic HIV DiseaseJAIDS Journal of Acquired Immune Deficiency Syndromes, 1991
- Initial Clinical Experience with Dideoxynucleosides as Single Agents and in Combination TherapyAnnals of the New York Academy of Sciences, 1990
- Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexThe Lancet, 1990
- Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-dhoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replicationBiochemical Pharmacology, 1989
- Analytical Method for the Quantification of 2′,3′-Didehydro-3′-Deoxythymidine, a New Anti-Human Immunodeficiency Virus (HIV) Agent, by High-Performance Liquid Chromatography (HPLC) and Ultraviolet (UV) Detection in Rat and Monkey PlasmaPharmaceutical Research, 1989
- PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)The Lancet, 1988